Bill > HB4954

This bill, titled the 340B Drug Pricing Program Reporting Act, mandates that entities participating in the federal 340B Program, which allows certain healthcare organizations to purchase outpatient drugs at reduced prices, must report detailed information about their participation to the Department of Public Health annually. Specifically, by April 1st each year starting in 2027, these "340B covered entities" (defined as eligible organizations with a service address in Illinois, including their associated child sites or grantees) must submit data on their drug acquisition costs, dispensing payments, payments to contract pharmacies (pharmacies that dispense 340B drugs on behalf of a covered entity), how savings are used for charity care or community benefits, and their overall operating and charity care costs. The Department will then compile this information into a public report by November 15th each year, starting in 2027, and post it online. The bill also outlines penalties for late reporting, allows pharmaceutical manufacturers to request specific dispensing data from covered entities to prevent issues like duplicate discounts or diversion, and includes provisions for rulemaking and an exemption for manufacturers from certain restrictions. This Act will be repealed on January 1, 2031.

Government Affairs

https://www.ilga.gov/Legislation/BillStatus?DocNum=4954&GAID=18&DocTypeID=HB&SessionID=114&GA=104